Literature DB >> 1401061

Epidermal keratinocyte-derived basophil promoting activity. Role of interleukin 3 and soluble CD23.

A H Dalloul1, M Arock, C Fourcade, J Y Béranger, P Jaffray, P Debré, M D Mossalayi.   

Abstract

Human epidermal keratinocytes (EK) secrete factors able to sustain the proliferation of early myeloid cells and, in particular, the generation of basophils. This activity was previously attributed to IL-3, although no definitive in situ demonstration of this cytokine was provided. In regard to the possible physiological relevance of these data, we investigated herein the nature of EK-derived factors responsible for basophil promotion. Our data show that EK-derived supernatants (EK-sup) contain IL-3 as well as soluble CD23 (sCD23), both known for their colony stimulating activity. Messenger RNA for IL-3 and CD23 were also detected in EK. Blocking experiments using specific neutralizing monoclonal antibodies (mAb) further indicate that EK-derived basophil promoting activity is mainly due to the presence of IL-3 and sCD23 in EK-sup. Furthermore, by contrast to IL-3, sCD23 secretion by EK is cortisone sensitive and highly enhanced by IL-4, suggesting distinct regulatory mechanisms for their production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401061      PMCID: PMC443165          DOI: 10.1172/JCI115986

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

Review 1.  Expression, structure, and function of the CD23 antigen.

Authors:  G Delespesse; U Suter; D Mossalayi; B Bettler; M Sarfati; H Hofstetter; E Kilcherr; P Debre; A Dalloul
Journal:  Adv Immunol       Date:  1991       Impact factor: 3.543

2.  Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features.

Authors:  G C Avanzi; P Lista; B Giovinazzo; R Miniero; G Saglio; G Benetton; R Coda; G Cattoretti; L Pegoraro
Journal:  Br J Haematol       Date:  1988-07       Impact factor: 6.998

Review 3.  Keratinocyte-derived interleukin 3.

Authors:  T A Luger; A Kock; R Kirnbauer; T Schwarz; J C Ansel
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23.

Authors:  M D Mossalayi; M Arock; J M Bertho; C Blanc; A H Dalloul; H Hofstetter; M Sarfati; G Delespesse; P Debré
Journal:  Blood       Date:  1990-05-15       Impact factor: 22.113

5.  The thymus according to Schambacher: medullary ducts and reticular epithelium of thymus and thymomas.

Authors:  K J Shier
Journal:  Cancer       Date:  1981-09-01       Impact factor: 6.860

6.  Human thymic epithelial cells produce interleukin-3.

Authors:  A H Dalloul; M Arock; C Fourcade; A Hatzfeld; J M Bertho; P Debré; M D Mossalayi
Journal:  Blood       Date:  1991-01-01       Impact factor: 22.113

7.  Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23).

Authors:  G Delespesse; M Sarfati; R Peleman
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

8.  Human keratinocytes and epidermoid carcinoma cell lines produce a cytokine with interleukin 3-like activity.

Authors:  M Danner; T A Luger
Journal:  J Invest Dermatol       Date:  1987-04       Impact factor: 8.551

9.  Cloning and expression of the cDNA coding for a human lymphocyte IgE receptor.

Authors:  C Lüdin; H Hofstetter; M Sarfati; C A Levy; U Suter; D Alaimo; E Kilchherr; H Frost; G Delespesse
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

10.  Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon.

Authors:  T Bieber; A Rieger; C Neuchrist; J C Prinz; E P Rieber; G Boltz-Nitulescu; O Scheiner; D Kraft; J Ring; G Stingl
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

View more
  1 in total

1.  Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes.

Authors:  P A Bécherel; M D Mossalayi; F Ouaaz; L Le Goff; B Dugas; N Paul-Eugène; C Frances; O Chosidow; E Kilchherr; J J Guillosson
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.